Professional Documents
Culture Documents
Lazard has prepared the information herein based upon publicly available information and
for general informational purposes only. The information is not intended to be, and should
not be construed as, financial, legal or other advice, and Lazard shall have no duties or
obligations to you in respect of the information.
EUROPEAN SHAREHOLDER ACTIVISM: 2017 IN REVIEW CONFIDENTIAL
- Consolidation among active players and inflows into passive strategies are on the rise across Europe
- This trend is likely to accelerate in the near term, thereby increasing ownership concentration among European companies and thus giving more echo
to activists’ thesis
- Regulatory changes, with Mifid II and the Shareholders Rights directives, will likely favor development of shareholder activism
M&A and asset plays at targets are the major topics developed by activists to pursue value creation
- In a market ripe for M&A, event-driven activism and portfolio reshuffling are the main work streams of activists in their search for value
Activists increasingly ask for governance changes without necessarily demanding board representation
Management and board accountability are under close scrutiny from activists, as illustrated by the proxy fight launched by TCI at LSE
Small and mid-caps remain activists “sweet spot” in Europe
An increase in blue chip targets is nonetheless to be highlighted, mainly due to large US activists deploying capital in European companies, as
illustrated by Sachem Head at Shire, Third Point at Nestlé and Corvex at Clariant
Activism is expanding accross all European geographies, including Southern and Eastern Europe
Greece, Spain and Poland together account for c. 10% of campaigns, illustrated by important campaigns at blue chip companies such as Abertis and
OTE
With Europe going forward in a post-Brexit situation, activism is increasing on the continent
Source: Activist Insight, Activist Monitor, Press
Note: All following data as of 31/12/2017 1
EUROPEAN SHAREHOLDER ACTIVISM: 2017 IN REVIEW CONFIDENTIAL
3 20 4
11
3
8
3
5
12
6 7 8 21 €11.8bn
3 FRANCE – 26 Campaigns (7,11,8)
21 5 8 €1.3bn
5 NORDICS – 20 Campaigns (8,6,6)
3 4 7 €20.8bn
12 1 4 €24.2bn
WYSER-PRATTE 2 2 4 €1.3bn
12 3 €12.3bn
3 3 €0.6bn
Capital Deployment in European Campaigns Activists Globally Paid Significant Attention to Europe in 2017
Campaigns
for nearly 30% of
campaigns in 2017,
a 65% increase
over prior years
U.S. & Other U.S. & Other
83% 73%
2013–16 $10.7
$10.1 $9.9
Mean:$9.7
$8.2
Europe
19% Europe reached
Europe 35%of total activist
Capital Deployed
35% capital deployed in
2017 as ~$22 billion
went into new
European
2013 2014 2015 2016 2017 campaigns vs. an
U.S. & Other U.S. & Other average of ~$10
% of Total 81% 65% billion in 2013-16
Capital
Deployed 22% 14% 18% 27% 35%
By Activists
Globally
In 2017, large US activists have deployed significant capital in Europe, with European funds still representing the majority of activist campaigns
2015-2017 Distribution of Activist Fund Types 2017 Distribution of Activist Fund Types
Longstanding Longstanding
European Funds European Funds
51% 44%
70% of campaigns in 2017 led by Activist Hedge Funds have been launched by European Funds
41 38
54
34
18
14 15
12 12 10 11
6 4
63% 50% 48% 11% 17% 15% 7% 15% 23% 19% 18% 14%
2015 2016 2017 €100m-€2bn €2bn-€5bn €5bn-€20bn €20bn+
Real Estate
Industrials
Telecom
Consumer
PEI
Healthcare
Technology
Media
Institutions
Financial
Structure
Elliott took ~10% stake in Arcam after previously thwarting a GE deal with SLM
GE ultimately increased offer to a ~20% premium over original offer
TCI, after building a 2.7% stake in Abertis, publicly stated that it strongly supported the offer
Successful by Atlantia to buy Abertis
“Bumpitrage”
TCI benefited from Abertis’ share price rally amid speculation of a counter offer from ACS
Structure required 75% shareholder approval, allowing Elliott to hold out on behalf
of minority holders despite 62% of shares already having approved
Private equity group agreed to pay ~12% premium to original price
Longstanding shareholder TCI publicly opposed Safran’s bid to acquire Zodiac Aerospace,
asking for a share repurchase scheme instead
Despite threatening Safran’s board with legal action, TCI failed to convince shareholders to vote
Opposition to against the merger, though the deal structure and price were revised
Announced
Transactions Dissident group White Tale opposed the merger as value destructive, growing an initial 7%
stake to 15% over two months
After the proposed merger was terminated under shareholder pressure, White Tale demanded 3
Board seats and a strategic review process
Knight Vinke refused tender its ~5% stake to the Finland-based bidder
Elliott disclosed a ~5% stake, but has not yet disclosedobjectives
Petrus Advisers publicly opposed the transaction a year after it was first agreed, delayed by
Ongoing Immofinanz needing to sell its Russian assets before the merger
Campaign Petrus reiterated its opposition to the merger the following semester, outlining its plan to create
value at Immofinanz in a full-fledged activist white paper
Elliott called the $110 per share opportunistic and estimated value at 23% higher
Elliott retained UBS to perform a financial analysis valuing the company at $136.50
per share
# of Board seats won In the past 3 years, activists obtained # of Board campaigns
124 board seats in Europe
47 41
42
35 13
26 25
25 29
19 6 8
28
17 18 20 17
16
16 28
17
20 6
11
9 2 1
57%
6 6 5 15
2 4 1 2 13 14
2 1
45% 65% 30% 21% 18% 7
12% 5% 12% 20% 4% 12% 5 2
One Two Three Four + 2015 2016 2017
seat granted seats granted seats granted seats granted Settlements
25% 25% 12%
as % of total
2015 2016 2017 Campaigns settled Proxy access Proxy fight